Pharmaceutical companies from across the world along with government agencies have partnered to...
- Aducanumab’s surprising revival: how an Alzheimer’s drug came back from the dead
- Horizon 2020: a look back at flagship EU pharma projects
- Pharma Technology Focus: treating zebras
- Manufacturing medicines in space: how astronauts will make their own drugs
- BioNTech acquires T cell therapy-focused Neon for $67m
Covid-19: Pharmaceutical companies and agencies that partnered for coronavirus vaccine development
Pharmaceutical companies from across the world along with government agencies have partnered to develop a cure for the new coronavirus (Covid-19) that emerged from Wuhan, China.
Coronavirus outbreak: Vaccines/drugs in the pipeline for Covid-19
Here are the potential human coronavirus vaccines/drugs pharmaceutical companies across the world are developing following the Wuhan coronavirus outbreak (Covid-19).
Preclinical data of Gilead’s remdesivir raises hope for China trials
A study by the US National Institutes of Health (NIH) has demonstrated that Gilead’s antiviral drug, remdesivir, could prevent a type of coronavirus in monkeys.
Covid-19: Pittsburgh University work on vaccine; Vaxil finds candidate
The University of Pittsburgh, US, has begun efforts to develop a vaccine against the Covid-19 disease caused by the new severe acute respiratory syndrome coronavirus (SARS-CoV-2).
OSE Immunotherapeutics and MAbSilico enter AI partnership
French biotechnology firm OSE Immunotherapeutics has signed a three-year agreement with technology start-up MAbSilico to leverage artificial intelligence (AI) technology for the development of monoclonal antibody drugs.
Merck’s Keytruda achieves PFS in Phase III TNBC study
Merck has announced Keytruda (pembrolizumab) combined with chemotherapy met one of two primary endpoints, progression-free survival (PFS), in the Phase III KEYNOTE-355 study of triple negative breast cancer (TNBC) patients.
Vir Biotechnology discovers two antibodies against new coronavirus
US-based immunology company Vir Biotechnology has identified two monoclonal antibodies (mAbs) that can bind to the new coronavirus, 2019-nCoV or SARS-CoV-2.
Coronavirus (Covid-19) vaccine may be available in 18 months
At a two-day meeting being held in Geneva, the World Health Organization (WHO) director-general Dr Tedros Adhanom Ghebreyesus has said that a vaccine for the new coronavirus may be available in 18 months.
Pfizer and Astellas report OS data for Xtandi in non-metastatic CRPC
Japanese company Astellas and US-headquartered Pfizer have announced final overall survival (OS) for Xtandi (enzalutamide) in non-metastatic castration-resistant prostate cancer (nmCRPC).
Read our magazine
Pharma Technology Focus is the essential reading material for decision-makers in the pharmaceutical industry, bringing you the latest news and analysis in an exciting, interactive format.